(BDEC) Innovator SP500 Buffer - - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
BDEC: Options, ETF, FLEX
The Innovator S&P 500 Buffer ETF - December (BATS:BDEC) is a defined outcome ETF that primarily invests in FLEX Options, which are highly customizable exchange-traded option contracts. These options are tied to the performance of the SPDR® S&P 500® ETF Trust, providing exposure to the S&P 500 index with built-in downside protection. The funds strategy is designed to offer returns based on the S&P 500s performance while limiting losses within a specified range, typically over a one-year period. FLEX Options are guaranteed by the Options Clearing Corporation (OCC), but like all financial instruments, they carry counterparty risk with the OCC and may experience reduced liquidity compared to traditional options.
As a non-diversified fund, BDEC concentrates its investments in a limited number of FLEX Options, which can result in higher volatility and concentration risk. The funds structure is tailored for investors seeking a balance between growth potential and risk mitigation, particularly during periods of market uncertainty. Its use of FLEX Options allows for precise customization of strike prices and expiration dates, enabling the fund to target specific outcomes for its shareholders.
Over the next three months, BDEC is expected to trade within a narrow range, with technical indicators suggesting resistance near $44.50 and support at $42.80. The 20-day SMA of $43.96 and 50-day SMA of $43.70 indicate a neutral to slightly bearish outlook, while the 200-day SMA of $42.83 provides a longer-term support level. Average trading volume of 262,371 shares over the past 20 days suggests moderate liquidity, which could lead to occasional price gaps during high-volatility events. The ATR of 0.35 indicates low expected volatility, with daily price movements likely to remain subdued.
From a fundamental perspective, BDECs assets under management (AUM) of $331.31 million reflect moderate investor interest in defined outcome strategies. This level of AUM is sufficient to maintain liquidity but may limit the funds ability to capitalize on rapid market movements. The funds focus on the S&P 500, a widely followed and diversified index, provides a solid foundation for its investment strategy, though it remains vulnerable to broader market downturns.
Additional Sources for BDEC ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BDEC ETF Overview
Market Cap in USD | 317m |
Category | Defined Outcome |
TER | 0.79% |
IPO / Inception | 2019-11-29 |
BDEC ETF Ratings
Growth 5y | 81.3% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -4.89 |
Analysts | - |
Fair Price Momentum | 41.94 USD |
Fair Price DCF | - |
BDEC Dividends
No Dividends PaidBDEC Growth Ratios
Growth Correlation 3m | -10.2% |
Growth Correlation 12m | 87.8% |
Growth Correlation 5y | 89.5% |
CAGR 5y | 13.89% |
CAGR/Max DD 5y | 0.84 |
Sharpe Ratio 12m | 0.99 |
Alpha | -3.00 |
Beta | 0.43 |
Volatility | 18.33% |
Current Volume | 15.6k |
Average Volume 20d | 24.8k |
As of March 14, 2025, the stock is trading at USD 41.39 with a total of 15,559 shares traded.
Over the past week, the price has changed by -2.61%, over one month by -6.70%, over three months by -5.59% and over the past year by +2.94%.
Yes. Based on ValueRay Analyses, Innovator SP500 Buffer - (BATS:BDEC) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 81.33 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BDEC as of March 2025 is 41.94. This means that BDEC is currently overvalued and has a potential downside of 1.33%.
Innovator SP500 Buffer - has no consensus analysts rating.
According to ValueRays Forecast Model, BDEC Innovator SP500 Buffer - will be worth about 45.8 in March 2026. The stock is currently trading at 41.39. This means that the stock has a potential upside of +10.58%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 45.8 | 10.6% |